Fyodor is rapidly advancing the development of its innovative Urine Malaria Test (UMT), in-licensed from The Johns Hopkins University.  This platform technology provides a tool for the rapid diagnosis of clinical malaria from urine. The UMT is designed to detect one or more novel malaria-specific proteins present in the urine of clinically-infected people, and can easily be performed by an untrained individual using a urine sample. Initial preclinical validation testing performed by Johns Hopkins University demonstrated the assay to be highly accurate for the detection of clinical malaria in people with fever.